---
id: 1421620236831318016
author: PhilosopherMD1
published_date: 2021-07-31 23:54:11 +00:00
conversation_id: 1421615551374262272
in_reply_to: 1421615551374262272
retweet: None
quoted_tweet: None
type: tweet
tags:

---

@yudapearl Would not seeing ~5% survival benefit in early phase studies then testing for that difference in a well designed NHST phase 3 randomized trial not count? 5% wouldâ€™ve be seen empirically (not just made up) &amp; then deemed an appropriate efficacy endpt by experts. Thank you sir

### Metadata

Author: [[@PhilosopherMD1]]
Conversation: [[conversation-1421615551374262272]]
In reply to: [[1421615551374262272]]
Retweet of: [[None]]
Quoted tweet: [[None]]
